Bone morphogenetic protein antagonist gene NOG is involved in myeloproliferative disease associated with myelofibrosis

Cancer Genetics and Cytogenetics

Volumn 178, Issue 1, 2007, Pages 11-16

  Andrieux, Joris ^a   Roche Lestienne, Catherine ^a,b   Geffroy, Sandrine ^a   Desterke, Christophe ^c   Grardel, Nathalie ^a   Plantier, Isabelle ^d   Selleslag, Dominik ^e   Demory, Jean Loup ^f   Laï, Jean Luc ^a,b   Leleu, Xavier ^a   Le Bousse Kerdiles, Caroline ^c   Vandenberghe, Peter ^g  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c HÔPITAL PAUL BROUSSE   (France)

^d CENTRE HOSPITALIER DE ROUBAIX   (France)

^e Hematology Department   (Belgium)

^f UNIVERSITÉ CATHOLIQUE DE LILLE   (France)

^g UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; CYTOKINE RECEPTOR ANTAGONIST; NOGGIN; OSTEOGENIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CASE REPORT; CD34 SELECTION; CHROMOSOME 17Q; COMPARATIVE STUDY; DNA MICROARRAY; DOWN REGULATION; FEMALE; FIBROSIS; GENE EXPRESSION; HUMAN; MALE; MUTATION; MYELOFIBROSIS; MYELOID LEUKEMIA; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; OSTEOSCLEROSIS; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA; UPREGULATION;

ADULT; AGED, 80 AND OVER; BONE MORPHOGENETIC PROTEINS; CARRIER PROTEINS; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, X; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; MYELOFIBROSIS; MYELOPROLIFERATIVE DISORDERS; OSTEOSCLEROSIS; TRANSLOCATION, GENETIC;

BACTERIA (MICROORGANISMS);

EID: 34548674206     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2007.06.001     Document Type: Article

References (25)

1. Andrieux J., Demory J.L., Morel P., Plantier I., Dupriez B., Caulier M.T., Bauters F., and Lai J.L. Frequency of structural abnormalities of the long arm of chromosome 12 in myelofibrosis with myeloid metaplasia. Cancer Genet Cytogenet 137 (2002) 68-71
2. Andrieux J., Demory J.L., Dupriez B., Quief S., Plantier I., Roumier C., Bauters F., Lai J.L., and Kerckaert J.P. Dysregulation and overexpression of HMGA2 in myelofibrosis with myeloid metaplasia. Genes Chromosomes Cancer 39 (2004) 82-87
3. ISCN 2005: an international system for human cytogenetic nomenclature (2005). In: Shaffer L.G., and Tommerup N. (Eds) (2005), S. Karger, Basel
4. Saeed A.I., Sharov V., White J., Li J., Liang W., Bhagabati N., Braisted J., Klapa M., Currier T., Thiagarajan M., Sturn A., Snuffin M., Rezantsev A., Popov D., Ryltsov A., Kostukovich E., Borisovsky I., Liu Z., Vinsavich A., Trush V., and Quackenbush J. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34 (2003) 374-378
5. Martyre M.C., Le Bousse-Kerdiles M.C., Romquin N., Chevillard S., Praloran V., Demory J.L., and Dupriez B. Elevated levels of basic fibroblast growth factor in megakaryocytes and platelets from patients with idiopathic myelofibrosis. Br J Haematol 97 (1997) 441-448
6. Martyre M.C., and Le Bousse-Kerdiles M.C. French INSERM Research Network on Myelofibrosis with Myeloid Metaplasia. Stem cell dysregulation in myelofibrosis with myeloid metaplasia: current data on growth factor and transcription factor involvement. Semin Oncol 32 (2005) 373-379
7. Tefferi A. Pathogenesis of myelofibrosis with myeloid metaplasia. J Clin Oncol 23 (2005) 8520-8530
8. Hu Z., Peel S.A., Ho S.K., Sandor G.K., and Clokie C.M. Role of bovine bone morphogenetic proteins in bone matrix protein and osteoblast-related gene expression during rat bone marrow stromal cell differentiation. J Craniofac Surg 16 (2005) 1006-1014
9. Cohen Jr. M.M. TGFβ/Smad signaling system and its pathologic correlates. Am J Med Genet A 116 (2003) 1-10
10. Pera M.F., Andrade J., Houssami S., Reubinoff B., Trounson A., Stanley E.G., Ward-van Oostwaard D., and Mummery C. Regulation of human embryonic stem cell differentiation by BMP-2 and its antagonist noggin. J Cell Sci 117 (2004) 1269-1280
11. Xu R.H., Peck R.M., Li D.S., Feng X., Ludwig T., and Thomson J.A. Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat Methods 2 (2005) 185-190
12. Marcelino J., Sciortino C.M., Romero M.F., Ulatowski L.M., Ballock R.T., Economides A.N., Eimon P.M., Harland R.M., and Warman M.L. Human disease-causing NOG missense mutations: effects on noggin secretion, dimer formation, and bone morphogenetic protein binding. Proc Natl Acad Sci U S A 98 (2001) 11353-11358
13. Brown D.J., Kim T.B., Petty E.M., Downs C.A., Martin D.M., Strouse P.J., Moroi S.E., Gebarski S.S., and Lesperance M.M. Characterization of a stapes ankylosis family with a NOG mutation. Otol Neurotol 24 (2003) 210-215
14. Semonin O., Fontaine K., Daviaud C., Ayuso C., and Lucotte G. Identification of three novel mutations of the noggin gene in patients with fibrodysplasia ossificans progressiva. Am J Med Genet 102 (2001) 314-317
15. Fontaine K., Semonin O., Legarde J.P., Lenoir G., and Lucotte G. A new mutation of the noggin gene in a French fibrodysplasia ossificans progressiva (FOP) family. Genet Couns 16 (2005) 149-154
16. Devlin R.D., Du Z., Pereira R.C., Kimble R.B., Economides A.N., Jorgetti V., and Canalis E. Skeletal overexpression of noggin results in osteopenia and reduced bone formation. Endocrinology 144 (2003) 1972-1978
17. Glaser D.L., Economides A.N., Wang L., Liu X., Kimble R.D., Fandl J.P., Wilson J.M., Stahl N., Kaplan F.S., and Shore E.M. In vivo somatic cell gene transfer of an engineered Noggin mutein prevents BMP4-induced heterotopic ossification. J Bone Joint Surg Am 85 (2003) 2332-2342
18. Raida M., Clement J.H., Leek R.D., Ameri K., Bicknell R., Niederwieser D., and Harris A.L. Bone morphogenetic protein 2 (BMP-2) and induction of tumor angiogenesis. J Cancer Res Clin Oncol 131 (2005) 741-750
19. Deckers M.M., van Bezooijen R.L., van der Horst G., Hoogendam J., van Der Bent C., Papapoulos S.E., and Lowik C.W. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 143 (2002) 1545-1553
20. Langenfeld E.M., and Langenfeld J. Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors. Mol Cancer Res 2 (2004) 141-149
21. Sipe J.B., Zhang J., Waits C., Skikne B., Garimella R., and Anderson H.C. Localization of bone morphogenetic proteins (BMPs)-2, -4, and -6 within megakaryocytes and platelets. Bone 35 (2004) 1316-1322
22. Mesa R.A., Li C.Y., Ketterling R.P., Schroeder G.S., Knudson R.A., and Tefferi A. Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases. Blood 105 (2005) 973-977
23. Reilly J. Pathogenesis of idiopathic myelofibrosis: role of growth factors. J Clin Pathol 45 (1992) 461-464
24. Bergstrom K., and Van Slyke E. Acute myelofibrosis: an accelerated variant of agnogenic myeloid metaplasia. Ann Int Med 74 (1971) 232-235
25. Detmer K., Steele T.A., Shoop M.A., and Dannawi H. Lineage-restricted expression of bone morphogenetic protein genes in human hematopoietic cell lines. Blood Cells Mol Dis 25 (1999) 310-323